[Therapy of peripheral arterial occlusive diseases. Round table conference]. 1983

A Bollinger, and L Biland, and U Brunner, and A Kappert, and B Krähenbühl, and F Mahler, and M Monti, and B Nachbur, and E Schneider, and L K Widmer

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007261 Infusions, Intra-Arterial Regional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease. Infusions, Regional Arterial,Infusions, Intra Arterial,Infusions, Intraarterial,Arterial Infusion, Intra,Arterial Infusion, Regional,Arterial Infusions, Intra,Arterial Infusions, Regional,Infusion, Intra Arterial,Infusion, Intra-Arterial,Infusion, Intraarterial,Infusion, Regional Arterial,Intra Arterial Infusion,Intra Arterial Infusions,Intra-Arterial Infusion,Intra-Arterial Infusions,Intraarterial Infusion,Intraarterial Infusions,Regional Arterial Infusion,Regional Arterial Infusions
D007383 Intermittent Claudication A symptom complex characterized by pain and weakness in SKELETAL MUSCLE group associated with exercise, such as leg pain and weakness brought on by walking. Such muscle limpness disappears after a brief rest and is often relates to arterial STENOSIS; muscle ISCHEMIA; and accumulation of LACTATE. Claudication, Intermittent
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D004176 Dipyridamole A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) Antistenocardin,Apo-Dipyridamole,Cerebrovase,Cléridium,Curantil,Curantyl,Dipyramidole,Kurantil,Miosen,Novo-Dipiradol,Persantin,Persantine,Apo Dipyridamole,Novo Dipiradol
D004691 Endarterectomy Surgical excision, performed under general anesthesia, of the atheromatous tunica intima of an artery. When reconstruction of an artery is performed as an endovascular procedure through a catheter, it is called ATHERECTOMY. Thromboendarterectomy,Endarterectomies,Thromboendarterectomies
D005081 Exercise Therapy A regimen or plan of physical activities designed and prescribed for specific therapeutic goals. Its purpose is to restore normal musculoskeletal function or to reduce pain caused by diseases or injuries. Rehabilitation Exercise,Remedial Exercise,Therapy, Exercise,Exercise Therapies,Exercise, Rehabilitation,Exercise, Remedial,Exercises, Rehabilitation,Exercises, Remedial,Rehabilitation Exercises,Remedial Exercises,Therapies, Exercise
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Bollinger, and L Biland, and U Brunner, and A Kappert, and B Krähenbühl, and F Mahler, and M Monti, and B Nachbur, and E Schneider, and L K Widmer
April 1967, Naika. Internal medicine,
A Bollinger, and L Biland, and U Brunner, and A Kappert, and B Krähenbühl, and F Mahler, and M Monti, and B Nachbur, and E Schneider, and L K Widmer
May 1966, Naika. Internal medicine,
A Bollinger, and L Biland, and U Brunner, and A Kappert, and B Krähenbühl, and F Mahler, and M Monti, and B Nachbur, and E Schneider, and L K Widmer
October 1965, Seikeigeka. Orthopedic surgery,
A Bollinger, and L Biland, and U Brunner, and A Kappert, and B Krähenbühl, and F Mahler, and M Monti, and B Nachbur, and E Schneider, and L K Widmer
June 1966, Naika. Internal medicine,
A Bollinger, and L Biland, and U Brunner, and A Kappert, and B Krähenbühl, and F Mahler, and M Monti, and B Nachbur, and E Schneider, and L K Widmer
June 1966, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
A Bollinger, and L Biland, and U Brunner, and A Kappert, and B Krähenbühl, and F Mahler, and M Monti, and B Nachbur, and E Schneider, and L K Widmer
January 1993, Zeitschrift fur Kardiologie,
A Bollinger, and L Biland, and U Brunner, and A Kappert, and B Krähenbühl, and F Mahler, and M Monti, and B Nachbur, and E Schneider, and L K Widmer
September 1966, Nihon rinsho. Japanese journal of clinical medicine,
A Bollinger, and L Biland, and U Brunner, and A Kappert, and B Krähenbühl, and F Mahler, and M Monti, and B Nachbur, and E Schneider, and L K Widmer
November 1966, Naika. Internal medicine,
A Bollinger, and L Biland, and U Brunner, and A Kappert, and B Krähenbühl, and F Mahler, and M Monti, and B Nachbur, and E Schneider, and L K Widmer
October 1966, Naika. Internal medicine,
A Bollinger, and L Biland, and U Brunner, and A Kappert, and B Krähenbühl, and F Mahler, and M Monti, and B Nachbur, and E Schneider, and L K Widmer
January 1970, Naika. Internal medicine,
Copied contents to your clipboard!